Skip to main content
OpenTrials
Completed

NCT Number: NCT02460237

HPV Self-Test Intervention in Ohio Appalachia

This study will pilot test a culturally appropriate human papillomavirus (HPV) self-test intervention among women from Ohio Appalachia in order to determine the feasibility of HPV self-testing as a potential cervical cancer screening strategy. The intervention group will receive culturally appropriate materials and the control group will receive standard materials with their HPV self-test device.

Completed

Looking for future studies?

Notify Me

Key information

About this study

PRIMARY OBJECTIVES:

I. To determine the feasibility of HPV self-testing as a potential cervical cancer screening strategy and obtain preliminary efficacy data of culturally appropriate materials on self-test use.

OUTLINE:

Participants are randomized to 1 of 2 arms.

ARM I: Participants receive a study kit that includes culturally appropriate instructions for using and returning the HPV self-test device and a photo story information sheet about HPV and HPV self-testing. Participants are asked to complete the HPV self-test and return the test for HPV testing.

ARM II: Participants receive a study kit that includes standard instructions for using and returning the HPV self-test device and a standard information sheet about HPV and cervical cancer. Participants are asked to complete the HPV self-test and return the test for HPV testing.

Participants are followed up at 4 weeks for return of their HPV self-test device and then for 2 months after notification letters are sent.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages 30-65
  • No Pap test in the last 3 years
  • Resident of an Ohio Appalachia county
  • Not currently pregnant or was not pregnant in the last 3 months
  • No history of invasive cervical cancer
  • No history of hysterectomy; women will not be eligible for the pilot randomized controlled trial (RCT) if they participated in the focus groups that helped develop this study (focus groups were institutional review board [IRB] approved as Protocol 2014C0086) or the preliminary device test; we will also require women to read and understand English and have the ability to provide informed consent, which will be inferred upon completion and return of the study eligibility, consent, and Health Insurance Portability and Accountability Act (HIPAA) forms

Treatment and study plan

Disease Screening

Procedure

Complete HPV self-test

Other names: Disease Screening Procedure, Screening, Screening Intervention

Educational Intervention

Other

Receive culturally appropriate instructions for using and returning the HPV self-test device and a photo story information sheet about HPV and HPV self-testing

Other names: Education for Intervention, Intervention, Educational

Informational intervention

Other

Receive standard instructions and information sheet

laboratory biomarker analysis

Other

Correlative studies

Survey Administration

Other

Ancillary studies

Primary outcomes

  1. The proportion of women who return HPV-self tests

    Time frame: Up to 4 weeks from kit distribution

    A chi-square test will be used to test for a difference between the two groups.

Secondary outcomes

  1. Attendance at a follow-up health care visit after HPV testing notification letters are sent (attended or did not attend)

    Time frame: Up to 2 months after notification letters are sent

    Descriptive statistics (e.g., proportions) will be calculated for the entire sample and by study arm.

  2. Prevalence of HPV infection

    Time frame: After shipping the specimen, an expected average of 6 weeks

    Descriptive statistics (e.g., proportions) will be calculated for the entire sample and by study arm.

  3. Specimen adequacy (whether participants self-collected an adequate specimen [yes or no] to allow for HPV testing)

    Time frame: After shipping the specimen, an expected average of 6 weeks

    Descriptive statistics (e.g., proportions) will be calculated for the entire sample and by study arm.

Other outcomes

  1. Receipt of a Pap test (received or not received)

    Time frame: Up to 2 months after receiving notification letters are sent

    Descriptive statistics (e.g., proportions) will be calculated for the entire sample and by study arm.

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

Pilot Testing an HPV Self-Test Intervention: A Novel Strategy for Reducing Cervical Cancer in Appalachia

Important dates

Study start
2015
Primary completion
2016
Study completion
2017
First posted
Jun 2, 2015
Registry last updated
Feb 8, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.